KYMRKymera Therapeutics, Inc.

$125.37

Is it safe?

Can KYMR take a bad year?

The deepest fall in KYMR's price history on file is −88%; it is −1.5% below its high today.

34.28

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Cash runway
2.9 years

Cash runway · burning $59M a quarter at the current rate

Annualised volatility
70%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−88%

Worst drawdown on file · −1.5% today

Details
Cash and short-term investments
$691M
EBITDA, trailing twelve months
−$342M
Operating profit, trailing twelve months
−$350M
Annualised volatilitytwo years of daily moves
70%
Worst drawdown on file
−88%
Below its 52-week high
−1.5%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.